Spiro-oxindole compounds and their uses as therapeutic agents

Details for Australian Patent Application No. 2006235593 (hide)

Owner Xenon Pharmaceuticals Inc.

Inventors Chafeev, Mikhail; Chakka, Nagasree; Kamboj, Rajender; Bagherzadeh, Mehran Seid; Hsieh, Tom; Chowdhury, Sultan; Sun, Jianyu; Hou, Duanjie; Liu, Shifeng; Raina, Vandna; Fraser, Robert; Sun, Shaoyi; Fu, Jianmin; Sviridov, Serguei

Agent Davies Collison Cave

Pub. Number AU-B-2006235593

PCT Pub. Number WO2006/110917

Priority 60/670,896 11.04.05 US

Filing date 11 April 2006

Wipo publication date 19 October 2006

Acceptance publication date 5 July 2012

International Classifications

C07D 498/10 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/404

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2006/110917 Priority application(s): WO2006/110917

5 July 2012 Application Accepted

  Published as AU-B-2006235593

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006235598-System and method for treating vision refractive errors

2006235568-Method and system for an assessment within a multi-level organization